Adia Nutrition Inc. Announces Acquisition of Biolete, Expanding Its Portfolio With Organic Protein and Mushroom Coffee
Adia Nutrition Inc. Announces Acquisition of Biolete, Expanding Its Portfolio With Organic Protein and Mushroom Coffee
Winter Park, Florida--(Newsfile Corp. - July 23, 2024) - ADIA Nutrition Inc. (OTC Pink: ADIA), an innovative provider of nutritional supplements, is pleased to announce the acquisition of Biolete LLC, a pioneering company in the development of protein coffee with mushrooms. This strategic move marks a significant milestone for ADIA Nutrition as it continues to expand its portfolio and provide original solutions to meet the evolving needs of its customers.
佛罗里达州温特帕克——(新闻稿前披露-2024年7月23日)-ADIA营养品公司(OTC粉红股票代码:ADIA)是一家创新的营养补充剂供应商,很高兴宣布收购Biolete LLC,这是一家在蛋白质咖啡和蘑菇开发方面开创性的公司。这一战略举措标志着ADIA营养的一个重要里程碑,因为它继续扩大其投资组合,并提供原始解决方案,以满足其客户不断发展的需求。
Protein coffees and mushroom extracts have recently gained considerable attention for their potential health benefits, including increased energy, improved focus, and enhanced immune support. Biolete prides itself for its US manufactured coffee with organic ingredients of collagen protein and mushrooms which gives the energy-boosting benefits of coffee without the negative side effects. By acquiring 100% of Biolete, including its trademarks, inventory, customer base, and website, ADIA Nutrition is poised to strengthen its position in the rapidly growing functional beverage market.
蛋白质咖啡和蘑菇提取物因其潜在的健康益处而近来备受关注,包括增加能量,改善注意力和增强免疫支持功效。Biolete因其由胶原蛋白和蘑菇有机成分制成的美国制造咖啡而自豪,其具有咖啡增强能量的益处,而不会带来负面影响。通过收购Biolete的100%股权,包括其商标、库存、客户群和网站,ADIA营养有望在不断增长的功能性饮料市场中加强其地位。
"We are thrilled to welcome Biolete to the ADIA family," said Larry Powalisz, CEO of ADIA Nutrition Inc. "Biolete's innovative approach to combining the benefits of protein and mushrooms in a delicious coffee beverage aligns perfectly with our mission to revolutionize the supplement industry and empower individuals to prioritize their health and well-being. We are excited to leverage our combined resources and expertise to bring Biolete's exceptional product to a wider audience."
“我们非常高兴欢迎Biolete加入ADIA大家庭,”ADIA营养公司CEO拉里·波瓦里兹表示。 “Biolete在蛋白质和蘑菇结合成美味的咖啡饮料的创新方法与我们革命营养品行业和赋予个人优先考虑健康和福祉的使命完美契合。我们很兴奋利用我们的综合资源和专业知识,把Biolete杰出的产品带给更广泛的观众。”
Biolete accepted ADIA's equity offer of preferred shares that are regulated under Rule 144 (which does not affect the current outstanding shares of the company). This acquisition is a testament to ADIA's commitment to expanding its product offerings and delivering value to their shareholders.
Biolete接受了ADIA的优先股权报价,这些股票受144条规管制(不影响公司当前的流通股)。这项收购证明了ADIA扩大产品系列和为股东创造价值的承诺。
Kevin Masson, founder of Biolete, expressed his enthusiasm for the acquisition, stating, "I am excited to have sold Biolete to ADIA Nutrition as an equity investment. I believe that ADIA Nutrition is the perfect partner to help take Biolete to the next level and continue to provide our customers with the highest quality products."
Biolete创始人凯文·马松(Kevin Masson)对收购表示热情洋溢,称“我很兴奋把Biolete作为股权投资出售给ADIA营养。我相信ADIA营养是帮助Biolete走向更高水平的完美伙伴,并继续向我们的客户提供最高质量产品。”
The acquisition of Biolete is expected to immediately attribute to ADIA Nutrition's earnings and will provide new opportunities for growth and expansion. The company plans to integrate Biolete's operations seamlessly and add additional distribution channels to accelerate the adoption of its protein and mushroom coffee.
收购Biolete预计将立即对ADIA营养的收益产生贡献,并为增长和扩张提供新机会。该公司计划无缝地整合Biolete的运营,并添加其他分销渠道,以加速该公司的蛋白质和蘑菇咖啡的推广。
For media inquiries or further information, please contact Larry Powalisz at ceo@adiamed.com or 321-788-0850.
有关媒体查询或更多信息,请通过ceo@adiamed.com或321-788-0850联系Larry Powalisz。
Biolete.com
Biolete.com
adianutrition.com or X (Twitter) "adia_nutrition"
adianutrition.com或 X (Twitter) "adia_nutrition"
About ADIA Nutrition Inc.:
Adia Nutrition Inc. is a publicly traded company (OTC Pink: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division specializing in Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments for Multiple Sclerosis (MS). Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.
关于ADIA营养公司:
Adia营养公司是一家公开交易公司(OTC Pink:ADIA),致力于改革医疗保健和补充剂。公司专注于创新和质量,已建立了两个关键部门:提供高质量有机补充剂的补充部门和专门从事多发性硬化症(MS)的自体造血干细胞移植(aHSCT)治疗的医疗部门。通过这些部门,Adia营养公司致力于通过满足营养需求和突破性的医疗治疗措施来赋予个人更好的生活。
Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise.
安全港:本新闻稿包含根据1933年证券法第27A条和1934年证券交易法第21E条的前瞻性声明。这些前瞻性声明基于管理层的当前计划和期望,并受到一些不确定性和风险的影响,这些风险和不确定性可能会显著影响公司的当前计划和期望,以及未来的经营业绩和财务状况。关于公司业务前景以及可能影响公司业务前景并导致实际结果与前瞻性声明描述的结果有很大不同的风险和因素的更详细列表,可以在公司向证券交易委员会和OTC Markets,Inc. OTC Disclosure and News Service提交的报告和其他文件中找到。公司不承担公开更新或修订任何前瞻性声明的义务,因为有新信息,未来事件或其他情况。